November 19, 2026·35 min read

BellRing Brands (BRBR), Financial Analysis

Insights derived from analysing SEC filings. Independent analysis, not a publication of the SEC.

Net sales Q4 FY2026
$692.0m
+6.8% year on year (Q4 FY2025 $648.2m); FY2026 $2.40bn, +3.5%
Costs Q4 FY2026 (net sales less operating profit)
$624.2m
+14.3% year on year (Q4 FY2025 $546.0m)
Operating margin Q4 FY2026
9.8%
(6.0 pts) year on year (Q4 FY2025 15.8%); gross margin 22.0%
Key findings
  • Q4 FY2026 (quarter to 30 Sep 2026) net sales $692.0m, +6.8%, on volume +14.9% and price/mix (8.1%); FY2026 net sales $2.40bn, +3.5%. Premier Protein RTD shake net sales rose 7.9% in Q4 on volume +16.5% and price/mix (8.6%), with more promotions and distribution points +36%.
  • Gross margin fell to 22.0% in Q4 from 28.9% and to 26.6% in FY2026 from 33.3%: input cost inflation incl. tariffs, promotional investment, freight and about $37m of inventory related headwinds in FY2026 (about $16m in Q4: reserves for slow moving inventory and trade spend on excess shake bottle inventory). Net product costs rose $135.8m in FY2026 (10-K).
  • FY2026 operating profit $277.7m, (22.3%); net earnings $147.4m, (31.8%); diluted EPS $1.25 against $1.68; Adjusted EBITDA (company measure) $288.8m against $481.6m. The FY2026 Adjusted EBITDA outlook was cut from $425m to $455m (Nov 2025) to $275m to $295m (Aug 2026).
  • Dymatize net sales $309.8m, +10.7%, on price/mix +9.1%; Q4 Dymatize volume fell 14.6% after price increases. Powders rose +7.3% to $393.1m; Premier Protein powder consumption fell 1.8% in Q4 on reduced distribution and price elasticity (8-K Ex 99.2).
  • Cash: operating cash flow $126.0m against $260.6m after $90.0m of Joint Juice settlement payments; 4.9m shares repurchased at an average $27.41 (cash paid $137.2m against $474.9m), none in Q4; $506.9m of the $600m authorization left. Debt principal $1.05bn at 30 Sep 2026 against cash $20.1m; net debt 3.6x FY2026 Adjusted EBITDA (report calculation).
  • FY2027 outlook (18 Nov 2026): net sales $2.32bn to $2.42bn and Adjusted EBITDA $310m to $350m, about 14% of net sales; long term targets withdrawn. New CEO Michael Axelrod (from 29 Jul 2026) and CFO Travis Leonard (from 1 Dec 2026); a $100m gross supply chain savings program, about $25m in FY2027. Shares closed at $13.66 on 18 Nov 2026, 10.9x FY2026 EPS.

Figures are read from the filings of BellRing Brands, Inc. (central index key 1772016): the Q4 and FY2026 results release, supplemental presentation and CFO transition release (8-K Ex 99.1, 99.2 and 99.3 of 18 Nov 2026), the Form 10-K for FY2026 filed the same day, the Forms 10-Q for Q1 to Q3 FY2026, the Forms 10-K for FY2023 to FY2025, the Forms 8-K with all their exhibits, incl. the quarterly results releases with every guidance revision, the CEO appointment, the workforce realignment and the Item 5.07 vote results, Schedules 13G, Forms 4, and the filings of the peers in chapters 2 to 5. BellRing files no separate CFO commentary; CFO and CEO statements come from the 8-K exhibits. Earnings call statements are not used. Category and consumption data are the market data BellRing reports in its 8-K Ex 99.2. Share price $13.66 is the regular session close of 18 Nov 2026, the day of the release. Accession numbers appear in the Sources appendix.

1 Revenue & Business Model

  • Storyline: BellRing sells protein shakes and powders under Premier Protein and Dymatize; FY2026 net sales rose +3.5% as volume rose 7.6% and price/mix fell 4.1%, while gross margin fell 6.7 points. Chapter 2 covers Premier Protein RTD shakes, chapter 3 powders and chapter 4 protein costs and margins, each with industry change and competitors from their filings.
  • Product forms, FY2026: RTD shakes and other beverages $1.94bn (81.0% of net sales), powders $393.1m (16.4%), other $62.1m. Brands: Premier Protein $2.04bn (84.9%), Dymatize $309.8m (12.9%). Net sales grew from $1.37bn in FY2022, a 15.0% annual rate.
  • Customers: Walmart (incl. Sam's Club), Costco and Amazon took 73.6% of FY2026 net sales; the largest customer 35.3%. US 86.9% and international 13.1% of net sales (10-K).
  • Asset light model: third party contract manufacturers make most products; the largest supplied 42.3% of Premier RTD shakes in FY2026 under an agreement to 31 Dec 2030; one owned plant in Voerde, Germany; about 480 employees at 1 Nov 2026 (10-K).
Figure 1.1 Net sales and operating margin, FY2022 to FY2026
Figure 1.2 Net sales by product form, FY2022 to FY2026 ($bn)
Table 1.1 Net sales by product form and brand, Q4 and full year ($m)
LineQ4 FY2025Q4 FY2026Q4 growthFY2025FY2026FY2026 growth
RTD shakes and other beverages528.3568.8+7.7%1,893.61,943.2+2.6%
Powders104.9108.2+3.1%366.5393.1+7.3%
Other products15.015.0+0.0%56.562.1+9.9%
Net sales648.2692.0+6.8%2,316.62,398.4+3.5%
Brand: Premier Protein+7.1%1,990.22,036.0+2.3%
Brand: Dymatize+3.6%279.8309.8+10.7%
Brand: Other brands46.652.6+12.9%
Source: 10-K FY2026 and Forms 10-Q. Q4 product form values are derived (report calculation: full year in the 10-K less nine months in the Q3 10-Q); BellRing does not file a Q4 product split. Brand Q4 growth as stated in the 8-K Ex 99.1.
Table 1.2 Operating figures from the Forms 10-K
MetricFY2025FY2026
Marketing and consumer advertising ($m)75.291.2
Top three customers, share of net sales (%)74.073.6
Largest customer, share of net sales (%)34.335.3
International, share of net sales (%)11.913.1
Largest contract manufacturer, share of Premier RTD supply (%)n/a42.3
Purchase commitments ($m)n/a1,101.1
Effective tax rate (%)25.225.4
Diluted shares (m)128.5117.6
Customer shares from 10-K XBRL (three largest customers).

2 Premier Protein Shakes: Volume Bought With Promotion

  • RTD shakes and other beverages $1.94bn in FY2026, +2.6%, and $568.8m in Q4, +7.7%. Premier Protein RTD volume rose 8.4% in FY2026 while price/mix fell 5.8%.
  • By quarter in FY2026, Premier RTD net sales growth was (2.2%), +2.3%, +1.2%, +7.9%; price/mix (1.9%), (9.4%), (1.9%), (8.6%). The releases link the price/mix decline to incremental promotional investment.
  • Distribution and share (Ex 99.2): distribution points +36% in Q4; 23.1% dollar share of the US RTD category; household penetration of RTD 22.4%. Club consumption fell 6.4% over 52 weeks while mass rose 13.5%, food 21.6% and eCommerce 28.8%.
  • Supply: the largest contract manufacturer supplied 42.3% of Premier RTD shakes under an agreement to 31 Dec 2030; Q3 FY2026 carried a $10.0m charge for excess shake bottle inventory and Q4 about $8m of trade spend to sell that inventory through.
Figure 2.1 Premier Protein RTD volume and price/mix by quarter

How the RTD protein market is changing and how competitors compare

  • US wellness category dollar sales +8% in the 13 weeks to 27 Sep 2026; RTD +12% (volume +10%, price/mix +2%), RTD +11% over 52 weeks (BellRing 8-K Ex 99.2, 18 Nov 2026, market data as filed by BellRing).
  • 25% of RTD category volume was sold on price reduction in Q4 FY2026, 5 points more than a year earlier (BellRing 8-K Ex 99.2).
  • Premier Protein RTD 13 week consumption by channel: club +1.2%, mass +17.9%, food +25.5%, eCommerce +25.5%; over 52 weeks club (6.4%) (BellRing 8-K Ex 99.2).
  • Coca‑Cola disclosed a ransomware incident at fairlife on 16 Jul 2026 that temporarily suspended US fairlife production (Coca‑Cola 8-K Item 8.01).
  • Simply Good Foods OWYN net sales fell 20.6% in its Aug 2026 quarter and 9.7% in FY2026 on poor velocities; FY2027 group net sales guided (13%) to (17%) (8-K Ex 99.1, 27 Oct 2026).
Figure 2.2 Sales growth of protein and functional drink peers
Table 2.1 RTD protein and functional drinks against competitors, latest filed period ($m)
Company and measurePeriodFiled detailSales ($m)Growth (%)Gross margin (%)
BellRing RTD shakes and other beveragesSep 2026 quarter (Q4 FY2026)Premier RTD volume +16.5%, price/mix (8.6%)568.8+7.7%22.0
BellRing RTD shakes and other beveragesFY2026 (Sep 2026)Premier RTD volume +8.4%, price/mix (5.8%)1,943.2+2.6%26.6
Simply Good Foods, totalAug 2026 quarter (Q4 FY2026)OWYN (20.6%), Atkins (14.9%)333.3(9.7%)34.0
Abbott adult nutritionQ3 2026US adult $381m, +3.5%1,199.0+2.0%n/a
Celsius Alani NuQ3 2026company gross margin shown410.1+23.5%46.8
Post FoodserviceJun 2026 quarter (Q3 FY2026)volume +4.3%, incl. higher protein shake production652.9(6.5%)n/a
Post WeetabixJun 2026 quarter (Q3 FY2026)volume (3.8%)137.1(0.6%)n/a
Peer figures from each company's 8-K Ex 99.1; measures differ; BellRing and Celsius margins are company gross margins; n/a: not disclosed.

3 Powders: Dymatize Pricing Against Premier Powder Distribution

  • Powders $393.1m in FY2026, +7.3%; Dymatize $309.8m, +10.7%, on price/mix +9.1% and volume +1.6%. Q4 powders $108.2m, +3.1%.
  • Dymatize by quarter in FY2026: net sales +15.8%, (1.9%), +26.7%, +3.6%; Q3 price/mix +20.7% and Q4 +18.2% after inflation driven price increases, with Q4 volume (14.6%) as domestic demand reacted to the prices.
  • Premier Protein powder: 13 week consumption +2.9%, +3.1%, (4.2%) and (1.8%) through FY2026; distribution points fell on retailer discontinuations (Ex 99.2).
  • Input: milk and whey protein costs rose in FY2026 (10-K); the largest protein powder supply agreement, with minimum volumes, runs to 30 Jun 2028.
Figure 3.1 Dymatize volume and price/mix by quarter

How the powder market is changing and how competitors compare

  • US ready to mix (powder) category dollar sales +9% in the 13 weeks to 27 Sep 2026 with volume (2%) and price/mix +11%; over 52 weeks +9% with volume +5% and price/mix +4% (BellRing 8-K Ex 99.2, market data as filed by BellRing).
  • Premier Protein powder distribution points fell on retailer discontinuations; 13 week powder consumption by channel: mass +17.7%, eCommerce (3.0%), food (28.1%), club (13.6%) (BellRing 8-K Ex 99.2).
  • Dymatize 13 week consumption +12.1%: eCommerce +31.1%, club +336.2%, food (29.2%); tracked and untracked consumption covers about 50% of the global Dymatize business (BellRing 8-K Ex 99.2).
  • BellRing 10-K FY2026: milk based and whey based protein costs, freight, packaging and manufacturing faced inflation during FY2026; the largest protein powder supply agreement runs to 30 Jun 2028.
  • Simply Good Foods Quest net sales +0.7% in FY2026 while Atkins fell 20.9% (8-K Ex 99.1, 27 Oct 2026).
Figure 3.2 Powder and nutrition sales growth
Table 3.1 Powders and nutrition against competitors, latest filed period ($m)
Company and measurePeriodFiled detailSales ($m)Growth (%)Gross margin (%)
BellRing powdersSep 2026 quarter (Q4 FY2026)Premier powder consumption (1.8%)108.2+3.1%n/a
BellRing DymatizeFY2026 (Sep 2026)price/mix +9.1%, volume +1.6%309.8+10.7%n/a
Simply Good Foods, totalFY2026 (Aug 2026)Quest +0.7%, Atkins (20.9%)1,356.5(6.5%)32.6
Abbott nutrition, totalQ3 2026pediatric +8.8%, adult +2.0%2,262.0+5.1%n/a
Celsius Holdings, totalQ3 2026international +78%847.2+16.8%46.8
Peer figures from each company's own filings; n/a: not disclosed.

4 Protein Costs, Tariffs and the Margin Reset

  • Gross margin 26.6% in FY2026 against 33.3%, and 22.0% in Q4; adjusted gross margin, which excludes commodity hedge gains, 24.7% for FY2026 and 20.1% in Q4.
  • Drivers (10-K): net product costs +$135.8m from raw materials incl. tariffs, manufacturing, inventory adjustments ($18.1m reserves, $11.3m ingredient) and freight, partly offset by a $62.7m favorable change in commodity derivatives.
  • Adjusted EBITDA margin 12.0% in FY2026 against 20.8%; Q4 9.6%; the FY2027 outlook implies about 14%.
  • Response: pricing on Dymatize and Premier powder, a $100m gross supply chain savings program over three years and $10m to $12m of workforce savings.
Figure 4.1 Gross margin and Adjusted EBITDA margin by quarter

How input costs are changing across the sector and how competitors compare

  • Simply Good Foods FY2026 gross margin 32.6%, 360 basis points lower, on higher input costs; it guides FY2027 gross margin up 250 to 300 basis points with net sales (13%) to (17%) (8-K Ex 99.1, 27 Oct 2026).
  • Celsius Q3 2026 gross margin 46.8% against 51.3%, on aluminum and fuel inflation and a higher mix of DSD sales (8-K Ex 99.1, 5 Nov 2026).
  • Post Holdings Q3 FY2026 gross margin 29.1% against 30.0%; Foodservice net sales (6.5%) as avian influenza pricing lapped (8-K Ex 99.1, 6 Aug 2026).
  • BellRing 10-K FY2026: tariffs, geopolitical conflicts and trade policies raised input costs and had a material adverse effect on results; mitigation includes pricing, cost and inventory actions.
  • BellRing targets at least $100m of gross supply chain savings over three fiscal years, about $25m in FY2027 (10-K FY2026 Item 7).
Figure 4.2 Change in gross margin by company
Table 4.1 Gross margin change against competitors, latest filed period
CompanyPeriodGross marginChangeFiled detail
BellRingFY2026 (Sep 2026)26.6% against 33.3%(6.7 pts)Adjusted EBITDA margin 12.0% against 20.8%
BellRingSep 2026 quarter (Q4 FY2026)22.0% against 28.9%(6.9 pts)about $16m of inventory related actions
Simply Good FoodsFY2026 (Aug 2026)32.6% against 36.2%(3.6 pts)FY2027 gross margin guided +250 to 300 basis points
Celsius HoldingsQ3 202646.8% against 51.3%(4.5 pts)aluminum and fuel inflation, DSD mix
Post HoldingsJun 2026 quarter (Q3 FY2026)29.1% against 30.0%(0.9 pts)avian influenza pricing lapped
GAAP gross margin from each company's 8-K Ex 99.1.

5 Financial Analysis & Ratios

  • FY2026 net sales $2.40bn, +3.5%; gross margin 26.6% against 33.3%; operating profit $277.7m, (22.3%), a 11.6% margin against 15.4%. FY2025 operating profit included a $69.0m provision for the Joint Juice litigation; FY2026 SG&A fell to $343.4m from $396.0m.
  • Net earnings $147.4m, (31.8%); diluted EPS $1.25; adjusted EPS $1.04 against $2.17. Interest expense, net rose to $80.0m from $68.4m on higher revolver borrowing; effective tax rate 25.4%. GAAP results include $44.5m of mark to market gains on commodity hedges, which the company excludes from its adjusted measures.
  • Cash flow FY2026: operating cash flow $126.0m, (51.7%), after $90.0m of Joint Juice settlement payments; capex $9.4m; free cash flow $116.6m (4.9% of net sales).
  • Balance sheet at 30 Sep 2026: cash $20.1m; debt principal $1.05bn ($840m of 7.00% notes due Mar 2030 and $210m drawn on the $500m revolver, $287.6m available); stockholders' deficit $425.5m after repurchases.
Table 5.1 Income statement, cash flow and balance sheet summary ($m unless stated)
Line itemFY2022FY2023FY2024FY2025FY2026
Revenue1,371.51,666.81,996.22,316.62,398.4
Gross profit421.8530.2707.3770.4638.1
Selling, general and administrative189.7216.3284.6396.0343.4
Operating income212.4287.3387.7357.4277.7
Net income82.3165.5246.5216.2147.4
Diluted EPS ($)0.881.231.861.681.25
Operating cash flow21.0215.6199.6260.6126.0
Capital expenditure(1.8)(1.8)(1.8)(4.7)(9.4)
Free cash flow19.2213.8197.8255.9116.6
Stock based compensation9.814.221.022.123.5
Cash and investments35.848.470.871.820.1
Total debt929.5856.8833.11,084.31,045.6
Total equity(376.2)(323.5)(205.9)(453.9)(425.5)
Fiscal years end 30 September. Operating income is operating profit as filed. Total debt is long term debt at carrying amount (principal $1.05bn at 30 Sep 2026). FY2022 net income is net earnings available to common stockholders before the 2022 Spin‑off share basis. Stockholders' deficit in every year.
Figure 5.1 Quarterly revenue and margins
Table 5.2 What changed, Q4 FY2026 against Q4 FY2025
MetricQ4 FY2025Q4 FY2026Change
Revenue ($m)648.2692.06.8%
Gross profit ($m)187.4152.3(18.7%)
Operating income ($m)102.267.8(33.7%)
Net income ($m)59.635.6(40.3%)
Diluted EPS ($)0.480.31(35.4%)
Operating cash flow ($m)169.161.0(63.9%)
Free cash flow ($m)168.159.7(64.5%)
Operating margin (%)15.89.8(6.0 pts)
Net margin (%)9.25.1(4.1 pts)
Table 5.3 Ratio analysis
RatioFY2022FY2023FY2024FY2025FY2026
Growth and margins
Revenue growth (%)n/a21.519.816.13.5
Gross margin (%)30.831.835.433.326.6
Operating margin (%)15.517.219.415.411.6
Net margin (%)6.09.912.39.36.1
FCF margin (%)1.412.89.911.04.9
Cost and investment intensity
SBC (%) revenue0.70.91.11.01.0
Capex (%) revenue0.10.10.10.20.4
Effective tax rate (%)20.324.925.225.225.4
Returns
ROA (%)11.623.732.324.316.5
ROIC (%)32.744.552.147.934.5
Asset turnover (x)1.942.412.382.462.83
Liquidity and leverage
Current ratio (x)2.942.822.912.353.20
Net cash ($bn)(0.9)(0.8)(0.8)(1.0)(1.0)
Efficiency and cash quality
Days sales outstanding4637403533
Inventory days7762817867
FCF to net income (x)0.231.290.801.180.79
Shareholder returns (%) FCF2235974186118
ROE and debt to equity are not meaningful with a stockholders' deficit. BellRing pays no dividend; shareholder returns are repurchases.
Figure 5.2 Margin profile
Figure 5.3 Operating cash flow, capital expenditure and free cash flow
Table 5.4 Valuation snapshot at $13.66 per share, close 18 Nov 2026
MeasureValue
Market cap ($bn)1.6
Enterprise value ($bn)2.6
P/E (TTM) (x)10.9
EV/Sales (TTM) (x)1.1
EV/EBITDA (TTM) (x)9.1
FCF yield (%)7.3

Cost structure and profitability

  • Cost of goods sold 78.0% of Q4 net sales against 71.1%, and 73.4% for FY2026 against 66.7%; the release attributes the change to input cost inflation incl. tariffs, trade investment, freight and inventory related actions.
  • SG&A $343.4m (14.3% of net sales) against $396.0m (17.1%); FY2025 included the $69.0m legal provision. Marketing and consumer advertising rose to $91.2m from $75.2m.
  • Costs (net sales less operating profit) rose 14.3% in Q4 against net sales growth of 6.8%; Q4 operating margin 9.8% against 15.8%.
  • FY2026 Adjusted EBITDA outlook: cut twice, at Q2 and Q3, from $425m to $455m to $275m to $295m; the result was $288.8m.
Figure 5.4 FY2026 Adjusted EBITDA outlook by release
Table 5.5 Costs and profit as % of net sales, last five quarters
LineQ4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026Q4 FY2026
Cost of goods sold (% of net sales)71.170.173.071.478.0
Gross profit (% of net sales)28.929.927.028.622.0
Selling, general and administrative (% of net sales)12.514.515.316.411.6
Operating profit (% of net sales)15.814.611.011.59.8
Net earnings (% of net sales)9.28.15.76.05.1
Adjusted EBITDA (company measure) (% of net sales)18.116.89.013.79.6
Table 5.6 Q4 FY2026 against Q4 FY2025 ($m)
LineQ4 FY2025Q4 FY2026Change
Net sales648.2692.043.8
Cost of goods sold(460.8)(539.7)(78.9)
Gross profit187.4152.3(35.1)
Selling, general and administrative(80.9)(80.2)0.7
Amortization of intangible assets(4.3)(4.3)0.0
Operating profit102.267.8(34.4)
Interest expense, net(19.1)(20.0)(0.9)
Income tax(23.5)(12.2)11.3
Net earnings59.635.6(24.0)
Adjusted EBITDA (company measure)117.466.4(51.0)
Source: 8-K Ex 99.1 statement of operations.

Capital allocation and debt

  • Repurchases by quarter, FY2026 (as stated in the releases): $96.9m, $26.2m, $10.0m and none in Q4, 4.9m shares for $133.1m at $27.41; cash paid $137.2m incl. excise tax. FY2025 9.0m shares at $52.62, cash paid $474.9m. Diluted shares fell to 116.5m in Q4 from 125.3m.
  • Funding: cash paid for repurchases of $137.2m exceeded free cash flow of $116.6m; cash fell to $20.1m from $71.8m and the revolver balance fell to $210m from $250m.
  • Debt cost: interest expense, net $80.0m; weighted average rate 6.7%; net debt (principal less cash) 3.6x FY2026 Adjusted EBITDA (report calculation).
Figure 5.5 Repurchases, free cash flow and debt

6 MD&A & Management Commentary

Q4 FY2026 results release and supplemental presentation (8-K Ex 99.1 and 99.2, 18 Nov 2026)

  • Q4 FY2026: net sales $692.0m, +6.8%; Premier Protein +7.1% (volume +16.0%, price/mix (8.9%)); Dymatize +3.6% (price/mix +18.2%, volume (14.6%)); gross margin 22.0% against 28.9%; adjusted gross margin 20.1% against 29.7%.
  • Q4 earnings: operating profit $67.8m against $102.2m; net earnings $35.6m against $59.6m; EPS $0.31 against $0.48; adjusted EPS $0.22 against $0.51; Adjusted EBITDA $66.4m against $117.4m. Marketing rose $3.2m to $19.4m.
  • Q4 inventory actions: about $8m of reserves for slow moving inventory after the year end review and about $8m of trade spend to sell through excess RTD shake bottle inventory, together 230 basis points of gross margin.
  • Consumption (Ex 99.2): Premier RTD consumption +8.8% in the 13 weeks to 27 Sep 2026, its highest quarter; growth outside club +17%; 54% repeat rate; Premier RTD shipments exceeded consumption units in Q4.
  • Earlier FY2026 quarters: Q1 net sales $537.3m, +0.8%; Q2 $598.7m, +1.8% with an $11.3m ingredient charge; Q3 $570.4m, +4.2% with a $10.0m excess bottle charge.
  • FY2027 outlook: net sales $2.32bn to $2.42bn ((3.3%) to +0.9% on FY2026, report calculation); Adjusted EBITDA $310m to $350m, about 14% of net sales; capex $3m. Updated long term targets are due with Q2 FY2027 results.
Table 6.1 FY2027 outlook as filed in the 8-K Ex 99.1 of 18 Nov 2026
ItemOutlookSource
FY2027 net sales$2.32bn to $2.42bn8-K Ex 99.1, 18 Nov 2026
FY2027 Adjusted EBITDA$310m to $350msame
FY2027 Adjusted EBITDA % of net salesabout 14%same
FY2027 capital expenditure$3msame
Long term targetsnet sales growth 7% to 9% and Adjusted EBITDA margin 18% to 20% (Nov 2025) withdrawn; update due with Q2 FY2027 resultssame
Supply chain savings programat least $100m gross over three fiscal years; about $25m in FY202710-K FY2026 Item 7

Management and CFO commentary

  • BellRing files no separate CFO commentary document; management statements below come from the 8-K exhibits.
  • CEO Michael Axelrod, Q4 release (18 Nov 2026): Q4 Premier RTD consumption was the strongest of the year, consumption and sales ran ahead of guidance and profitability was in line; FY2027 is framed around strengthening the foundation, execution and cost savings, with a refreshed strategy and long term targets later in FY2027.
  • Outlook revisions: the FY2026 net sales outlook moved from $2.41bn to $2.49bn (Nov 2025) to $2.335bn to $2.375bn (Aug 2026); actual $2.40bn. The Adjusted EBITDA outlook fell from $425m to $455m to $275m to $295m; actual $288.8m.
  • CFO transition release (Ex 99.3): Travis Leonard, previously CFO of Lockton and Hostess Brands, replaces Paul Rode on 1 Dec 2026; Paul Rode advises until 28 Feb 2027.
Table 6.2 Management statements in their own words
SpeakerDate and sourceStatement
Michael Axelrod, President and CEO18 Nov 2026, 8-K Ex 99.1“Fiscal 2027 will be a year of strengthening our foundation”
Table 6.3 Key disclosures in the Form 10-K for FY2026
ItemDisclosure
Item 7, cost programSupply chain optimization targeting at least $100m of gross savings over three fiscal years from co manufacturing, procurement, distribution and packaging; about $25m in FY2027.
Item 7, operating profitOperating profit (22%): net product costs +$135.8m, advertising +$16.0m, reorganization $5.9m, against the $69.0m legal provision of FY2025; commodity derivatives a $62.7m favorable change.
Item 7, inventoryInventory adjustments of $18.1m of excess inventory reserves and an $11.3m charge for a supplier ingredient that missed quality requirements.
Item 7, tariffsTariffs, geopolitical conflicts and trade policies raised raw material, packaging, manufacturing and freight costs, with a material adverse effect on results.
Item 7, liquidityRevolver borrowings $420.0m and repayments $460.0m in FY2026; $287.6m available at 30 Sep 2026; weighted average interest rate 6.7% against 7.1%.
Item 7, commitmentsPurchase commitments $1.10bn, of which $559.3m due in FY2027, extending to FY2033.
Item 5, repurchases$506.9m left under the $600m authorization that expires 19 Nov 2027; no repurchases in Q4 FY2026.
Note 14, litigationSecurities class action filed 22 Jan 2026; on 28 Jul 2026 the court dismissed claims for 6 Aug 2024 to 5 May 2025 and kept claims for 6 May 2025 to 4 May 2026; class certification hearing 3 Dec 2026; derivative suits in Delaware.
Note 14, Joint Juice$90.0m paid into settlement funds in FY2026; all Joint Juice liabilities settled at 30 Sep 2026.
Table 6.4 Net sales growth, volume, price/mix and consumption by quarter (% year on year)
MeasureQ4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026Q4 FY2026FY2026
Total net sales, growth+16.6%+0.8%+1.8%+4.2%+6.8%+3.5%
Total net sales, volume+19.2%+0.7%+10.8%+1.7%+14.9%+7.6%
Total net sales, price/mix(2.6%)+0.1%(9.0%)+2.5%(8.1%)(4.1%)
Premier Protein, growth+14.9%(1.2%)+1.7%+0.7%+7.1%+2.3%
Premier Protein, volume+18.4%(0.2%)+11.3%+1.5%+16.0%+7.8%
Premier Protein, price/mix(3.5%)(1.0%)(9.6%)(0.8%)(8.9%)(5.5%)
Premier Protein RTD, growth+14.1%(2.2%)+2.3%+1.2%+7.9%+2.6%
Premier Protein RTD, volume+18.4%(0.3%)+11.7%+3.1%+16.5%+8.4%
Premier Protein RTD, price/mix(4.3%)(1.9%)(9.4%)(1.9%)(8.6%)(5.8%)
Dymatize, growth+32.9%+15.8%(1.9%)+26.7%+3.6%+10.7%
Dymatize, volumen/an/a(6.8%)+6.0%(14.6%)+1.6%
Dymatize, price/mixn/an/a+4.9%+20.7%+18.2%+9.1%
Premier RTD consumption+20.4%(2.2%)+2.9%+6.0%+8.8%n/a
Premier powder consumption+16.9%+2.9%+3.1%(4.2%)(1.8%)n/a
Dymatize consumption(1.5%)+7.5%+6.0%+2.7%+12.1%n/a
As stated in each 8-K Ex 99.1; consumption is 13 week US dollar consumption incl. estimated untracked channels. n/a: not stated.
Table 6.5 FY2026 outlook, every version, against the result
Measure18 Nov 20253 Feb 20265 May 20264 Aug 2026FY2026 actual
Net sales$2.41bn to $2.49bn$2.41bn to $2.46bn$2.325bn to $2.365bn$2.335bn to $2.375bn$2.40bn
Adjusted EBITDA$425m to $455m$425m to $440m$315m to $335m$275m to $295m$288.8m
Long term targetssales +7% to 9%; margin 18% to 20%unchangedunchangedunchangedwithdrawn 18 Nov 2026
Source: 8-K Ex 99.1 results releases. Adjusted EBITDA is a company measure.

7 Peer Valuation & Sector Summary

  • Peer set: Simply Good Foods (Quest, Atkins, OWYN nutrition bars, shakes and powders), Celsius Holdings (functional drinks incl. Alani Nu) and Post Holdings (former parent, cereal, eggs and protein shake production). Periods differ: BellRing FY2026 to Sep 2026, Simply Good Foods FY2026 to Aug 2026, Celsius TTM to Sep 2026, Post TTM to Jun 2026.
  • Growth, latest quarter year on year: Celsius +16.8%, BellRing +6.8%, Post (1.8%), Simply Good Foods (9.7%).
  • Margins: gross margin Celsius 47.6%, Simply Good Foods 32.6%, Post 28.8%, BellRing 26.6%; operating margin Celsius 13.0%, BellRing 11.6%, Post 9.6%, Simply Good Foods (13.2%) after a $331.0m impairment.
  • Cash and leverage: free cash flow margin Simply Good Foods 11.6%, Celsius 8.5%, Post 6.6%, BellRing 4.9%. Net debt Post $7.37bn, BellRing $1.03bn, Simply Good Foods $0.21bn; Celsius net cash $26m.
  • Valuation (18 Nov 2026 closes): P/E TTM Celsius 36.8x, Post 14.7x, BellRing 10.9x; Simply Good Foods loss making. EV/Sales Celsius 2.6x, Post 1.3x, BellRing 1.1x, Simply Good Foods 1.0x.
Table 7.1 Peer comparison, latest filed periods to Sep 2026
CompanyRevenue TTM ($bn)Revenue growth (%)Gross margin (%)Operating margin (%)Net margin (%)FCF margin (%)ROE (%)Net cash ($bn)Market value ($bn)EV/Sales (x)P/E TTM (x)
BRBR2.46.826.611.66.14.9n/a(1.0)21.110.9
SMPL1.4(9.7)32.6(13.2)(11.5)11.6(9.6)(0.2)11.0n/a
CELH3.216.847.613.07.38.518.60.082.636.8
POST8.4(1.8)28.89.63.56.68.3(7.4)41.314.7
BellRing: FY2026 to 30 Sep 2026; Simply Good Foods: FY2026 to 29 Aug 2026 (operating loss includes a $331.0m impairment); Celsius: TTM to 30 Sep 2026, net income to common; market value on 250.6m common shares at 31 Oct 2026 (10-Q cover), convertible preferred stock excluded; Post Holdings: TTM to 30 Jun 2026 (Q4 FY2026 not filed by 19 Nov 2026). Growth is latest quarter year on year. Prices are 18 Nov 2026 closes; market values unrounded: BellRing $1.59bn, Simply Good Foods $1.10bn (86.9m shares at 22 Oct 2026), Celsius $8.21bn, Post Holdings $3.55bn (44.0m shares at 3 Aug 2026). ROE not meaningful for BellRing (stockholders' deficit).
Figure 7.1 Revenue growth versus operating margin, peer set

8 Material Events & Contracts

  • 9 Forms 8-K between 19 Nov 2025 and 18 Nov 2026: four results releases with three FY2026 outlook revisions, the $600m repurchase authorization, a CEO retirement and successor, retention grants, a workforce realignment and the Item 5.07 vote results.
  • Leadership: CEO Darcy Davenport announced her retirement on 3 Feb 2026; Michael Axelrod became CEO on 29 Jul 2026; Chief Growth Officer Douglas Cornille left on 1 Sep 2026; CFO Paul Rode is succeeded by Travis Leonard on 1 Dec 2026.
  • Cost actions: the Jun 2026 workforce realignment carries about $6m of charges and $10m to $12m of annual savings; the 10-K adds a $100m gross supply chain savings program over three fiscal years.
  • Litigation: a securities class action filed in Jan 2026 continues for statements between 6 May 2025 and 4 May 2026; the Joint Juice cases were settled with $90.0m paid in FY2026.
Table 8.1 Forms 8-K filed between 19 Nov 2025 and 18 Nov 2026
DateItemsEvent
20 Nov 20258.01, 9.01New $600m share repurchase authorization to 19 Nov 2027; the prior $400m authorization (about $123m used) was cancelled (Ex 99.1). (0001628280-25-053329)
2 Feb 20265.07Annual meeting of 28 Jan 2026: five directors elected (Robert Vitale 73.9% of votes cast); PwC ratified with 99.98% of votes cast; say on pay 82.6% of votes cast. (0001628280-26-004642)
3 Feb 20262.02, 5.02, 9.01Q1 FY2026 results: net sales $537.3m, +0.8%; Adjusted EBITDA $90.3m; FY2026 outlook narrowed to $2.41bn to $2.46bn and $425m to $440m (Ex 99.1, 99.2). CEO Darcy Davenport to retire (Ex 99.3). (0001628280-26-004789)
23 Feb 20265.02Retention RSU grants to four executives during the CEO transition, $451k to $551k each, vesting after one year. (0001628280-26-010629)
5 May 20262.02, 9.01Q2 FY2026 results: net sales $598.7m, +1.8% (volume +10.8%, price/mix (9.0%)); $11.3m ingredient charge; FY2026 outlook cut to $2.325bn to $2.365bn and Adjusted EBITDA $315m to $335m (Ex 99.1, 99.2). (0001628280-26-030115)
24 Jun 20265.02, 8.01Workforce realignment: about $6m of one time charges, $10m to $12m of annual savings; Chief Growth Officer Douglas Cornille leaves 1 Sep 2026. (0001628280-26-045287)
8 Jul 20265.02, 7.01, 9.01Michael Axelrod appointed President and CEO from 29 Jul 2026: salary $1.0m, equity award $4.75m (Ex 99.1). (0001628280-26-047674)
4 Aug 20262.02, 9.01Q3 FY2026 results: net sales $570.4m, +4.2%; $10.0m excess bottle inventory charge; FY2026 Adjusted EBITDA outlook cut to $275m to $295m (Ex 99.1, 99.2). (0001628280-26-052137)
18 Nov 20262.02, 5.02, 7.01, 9.01Q4 FY2026 results: net sales $692.0m, +6.8%; FY2026 $2.40bn, +3.5%; FY2027 outlook net sales $2.32bn to $2.42bn, Adjusted EBITDA $310m to $350m; long term targets withdrawn (Ex 99.1, 99.2). CFO Paul Rode succeeded by Travis Leonard from 1 Dec 2026 (Ex 99.3). (0001628280-26-074645)
Table 8.2 Material contracts and financing arrangements
ContractTerms
7.00% senior notes$840.0m due Mar 2030; indenture limits debt, liens, dividends and repurchases, with suspension if rated investment grade.
Credit agreement, first amendment (Aug 2025)$500m revolver to 22 Aug 2030 (14 Dec 2029 if the notes are not refinanced); $210.0m drawn at 30 Sep 2026; 6.16% rate.
Contract manufacturing agreementLargest RTD contract manufacturer, 42.3% of Premier RTD supply in FY2026, minimum quarterly volumes, expires 31 Dec 2030 (10-K).
Protein powder supply agreementMinimum periodic purchase volumes with the largest protein powder supplier, expires 30 Jun 2028 (10-K).
Share repurchase authorization$600m from 19 Nov 2025 to 19 Nov 2027; $506.9m left at 30 Sep 2026.
CEO and CFO agreementsCEO: salary $1.0m, $4.75m equity award, severance 2.0x (3.0x on change in control), transaction bonus of one year salary; CFO: salary $580k, $985k equity award, severance 1.0x (2.0x).

9 Ownership, Voting Power & Annual Meeting

  • One class of common stock: 116,387,850 shares outstanding at 12 Nov 2026 (10-K cover), against 118.4m entitled to vote at the Jan 2026 meeting. Holders of 5% or more in Schedules 13G: BlackRock 7.7% and Goldman Sachs 6.7% at 30 Sep 2026; Vanguard Capital Management 5.2% and Vanguard Portfolio Management 5.11% at 31 Mar 2026.
  • Holder turnover in 2026: AQR reported 7.28% at 31 Mar 2026 and 0.36% at 30 Sep 2026; Ameriprise 5.0% at 30 Jun 2026 and 1.4% at 30 Sep 2026; Wasatch 1.7% at 31 Mar 2026 against 5.4% at 30 Sep 2025.
  • Annual meeting of 28 Jan 2026 (8-K Item 5.07): five directors elected; Chairman Robert Vitale received 73.9% of votes cast against 94.7% to 98.8% for the other nominees; say on pay 82.6%.
  • Insiders, Forms 4 of the last twelve months: directors David Finkelstein bought 6,000 shares at $17.75 and $9.24 and Shawn Conway 2,022 shares at $9.89; Chief Growth Officer Douglas Cornille sold 3,970 shares at $30.93 under a Rule 10b5‑1 plan in Dec 2025. Directors on the CEO search committee received RSU grants.
Table 9.1 Annual meeting vote results, 28 Jan 2026
ProposalFor (m votes)Against (m votes)Abstain (m votes)For as % of votes castResult
Elect Robert V. Vitale69.524.60.073.9Elected
Elect Darcy H. Davenport92.51.60.098.3Elected
Elect David I. Finkelstein93.01.20.098.8Elected
Elect Chonda J. Nwamu92.51.60.098.3Elected
Elect Elliot H. Stein, Jr.89.15.00.094.7Elected
Ratify PricewaterhouseCoopers for FY2026100.10.00.3100.0Approved
Say on pay (advisory)77.516.30.382.6Approved
Director votes are For and Withhold (Withhold shown as Against). Broker non votes 6.24m on every item except the auditor ratification. Source: Form 8-K Item 5.07 of 2 Feb 2026 (linked in the Sources table).

Annual meeting remarks

  • No management remarks or shareholder questions from the virtual meeting of 28 Jan 2026 were filed; the Item 5.07 filing reports vote counts only.
Table 9.2 Holders of 5% or more in Schedules 13G
HolderShares (m)Share of class (%)Basis
BlackRock, Inc.9.007.713G/A 27 Oct 2026, at 30 Sep 2026
The Goldman Sachs Group, Inc.7.776.713G 9 Nov 2026, at 30 Sep 2026
Vanguard Capital Management6.115.213G 3 Sep 2026, at 31 Mar 2026
Vanguard Portfolio Management6.005.1113G 3 Sep 2026, at 31 Mar 2026
AQR 0.36% at 30 Sep 2026 (7.28% at 31 Mar 2026); Ameriprise 1.4% at 30 Sep 2026 (5.0% at 30 Jun 2026); Wasatch 1.7% at 31 Mar 2026 (5.4% at 30 Sep 2025); Millennium 3.6% at 23 Jun 2026.
Table 9.3 Open market transactions on Forms 4, 19 Nov 2025 to 18 Nov 2026
InsiderTypeSharesPrice ($)
David Finkelstein, director (29 Jan 2026)Purchase2,00017.75
David Finkelstein, director (13 May 2026)Purchase4,0009.24
Shawn Conway, director (8 Sep 2026)Purchase2,0229.89
Douglas Cornille, Chief Growth Officer, Rule 10b5‑1 sale (1 Dec 2025)Sale3,97030.93
Purchases $92k in total; sale $123k under a Rule 10b5‑1 plan. Award grants, tax withholding and deferred director fees are excluded.

10 Risk Factors

  • Item 1A of the FY2026 Form 10-K holds 48 risk factors, as a year earlier (15,851 words against 16,036): two added (AI and technology adoption; securities litigation and stockholder activism), two Spin‑off tax factors removed and five materially reworded, incl. the dependence on RTD beverages, labor costs, tax and interest rates.
Table 10.1 Risk factors with filed figures
RiskDisclosure and change
Dependence on Premier Protein RTD shakesRTD Beverages 81.0% of FY2026 net sales; Q4 price/mix (8.6%) on Premier RTD as promotions rose.
Customer concentrationWalmart, Costco and Amazon 73.6% of FY2026 net sales; no material long term supply agreements with customers.
Contract manufacturers and suppliersOne manufacturer supplied 42.3% of Premier RTD shakes; sole supplier for aseptic packaging; purchase commitments $1.10bn.
Protein and input costs, tariffsNet product costs +$135.8m in FY2026; gross margin 26.6% against 33.3%; hedges change fair value by about $14m per 10% price move.
DebtDebt principal $1.05bn against FY2026 Adjusted EBITDA $288.8m; 7.00% notes due Mar 2030 and revolver to Aug 2030.
Securities litigationClass action for 6 May 2025 to 4 May 2026 continues; class certification hearing 3 Dec 2026; derivative suits pending.
Leadership changeNew CEO from 29 Jul 2026 and new CFO from 1 Dec 2026; long term targets withdrawn pending a strategy review.

How risk factors changed

  • Comparison: 10-K FY2026 filed 18 Nov 2026 against 10-K FY2025 filed 18 Nov 2025.
  • The FY2026 10-K adds a stand alone factor on securities litigation and stockholder activism after the January 2026 class action.
  • AI is named in a new factor on technology adoption.
  • Two spin off tax factors were removed four years after the 2022 separation from Post.
Figure 10.1 Risk factors by change against the prior filing
Table 10.2 Size of the risk factor section
Measure10-K FY202510-K FY2026
Risk factors (count)4848
Words in Item 1A16,03615,851
Table 10.3 Risk factors added, removed and materially reworded
ChangeRisk factorWhat changed
AddedModernizing and adopting new technologies incl. AINew factor: competitors may adopt AI and new technologies faster; misuse or inaccurate AI outputs may harm reputation.
AddedSecurities litigation and stockholder activismNew factor: BellRing and current and former officers and directors are defendants in a securities class action and derivative suits filed in 2026.
RemovedTax liabilities relating to the spin offRemoved.
Removedspin off failing to qualify as tax freeRemoved.
RewordedDependence on RTD shakes and other beveragesHeading widened from RTD protein shakes to RTD shakes and other beverages; RTD Beverages 81.0% of FY2026 net sales.
RewordedLabor related costsAdds wage inflation, competition for talent and healthcare cost inflation; about 480 employees at 1 Nov 2026.
RewordedChanges in tax lawsAdds federal, state, local and foreign tax law changes and audits by taxing authorities.
RewordedInterest ratesAdds that rising rates may limit new borrowing or refinancing on acceptable terms.
RewordedStandalone corporate infrastructure costsUpdated for the expiry of the master services agreement with Post.

11 Stock Price, Scenarios & Sensitivity

  • BRBR closed at $13.66 on 18 Nov 2026, the day of the release, against $11.01 on 17 Nov 2026 (+24.1%); (55.8%) on the Nov 2025 month end close of $30.89 and (37%) on Nov 2021. Highest month end close in five years $78.46 (Nov 2024); intraday range over 52 weeks $7.34 to $33.52.
  • Valuation: market value $1.59bn on 116.39m shares; enterprise value $2.62bn incl. net debt of $1.03bn; 10.9x FY2026 EPS and 13.1x adjusted EPS; 9.1x FY2026 Adjusted EBITDA and 7.9x the FY2027 outlook midpoint of $330m; free cash flow yield 7.3%.
  • Scenario basis: GAAP P/E. Net sales grow from FY2026 for three years to FY2029 at an assumed operating margin of 8% to 15% (filed: 11.6% in FY2026, 9.8% in Q4). All inputs are this report's assumptions: net interest $80m a year (FY2026 level); tax rate 25% (FY2026 25.4%); shares 0% to 5% below 116.39m. FY2029 EPS times an exit P/E of 9x to 16x gives the implied price.
  • Price chart: monthly closes for five years, the last at 18 Nov 2026, followed by the best, base and worst case paths at the end of each of the next three years.
Figure 11.1 BRBR monthly closing price and three year scenarios

Critical factors and core assumptions

Table 11.1 Critical factors behind the best case
FactorCurrent valueBest case requiresEvidence in filings
Premier RTD price/mix(8.6%) in Q4 FY2026promotional spend stabilizes and price/mix turns flat8-K Ex 99.1; 25% of RTD category volume on price reduction (Ex 99.2)
Premier RTD volume and distributionvolume +16.5%, distribution points +36% in Q4distribution gains hold with lower promotion8-K Ex 99.2
Protein and input costsgross margin 26.6% FY2026cost inflation and tariffs ease; gross margin back near 30%10-K Item 7: net product costs +$135.8m
Supply chain savingsprogram announced Nov 2026$100m gross savings delivered over three years10-K Item 7; about $25m in FY2027
Club channelPremier RTD club consumption (6.4%) over 52 weeksclub returns to growth8-K Ex 99.2
Leverage3.6x net debt to Adjusted EBITDAdebt paid down from free cash flow before the 2030 maturities10-K Note 13
  • Base year (filed): FY2026 net sales $2.40bn, operating margin 11.6%; FY2027 outlook net sales $2.32bn to $2.42bn and Adjusted EBITDA $310m to $350m.
  • Best case (report assumption): +4% net sales CAGR as promotions ease and distribution holds; 15% operating margin with $100m of savings; 16x P/E; 5% fewer shares.
  • Base case (report assumption): +1% CAGR (the FY2027 outlook midpoint of $2.37bn is (1.2%) on FY2026); 12% operating margin; 12x P/E; 2% fewer shares.
  • Worst case (report assumption): (3%) CAGR on share loss and club weakness; 8% operating margin as costs stay high; 9x P/E; no change in shares.
  • All cases (report assumptions): net interest $80m a year; tax rate 25%; EPS on shares outstanding (116.39m at 12 Nov 2026 less the assumed reduction); no dividends.

Scenarios, three years forward

Table 11.2 Scenario analysis, FY2026 to FY2029
MeasureWorst caseBase caseBest case
Revenue CAGR, 3 years (%)(3.0)1.04.0
Revenue, FY2029 ($bn)2.22.52.7
Operating margin, FY2029 (%)8.012.015.0
Net income, FY2029 ($bn)0.10.20.2
EPS, FY2029 ($)0.611.422.20
Exit P/E (x)9.012.016.0
Implied price ($)5.5217.0935.24
Change against $13.66 (%)(60)25158
Implied annual return (%)(26.1)7.737.1
DescriptionShare loss and persistent cost inflationNet sales near the FY2027 outlook (report assumption)Promotions ease and savings arrive
All scenario inputs are this report's assumptions, not company guidance. Operating margin is operating profit over net sales; EPS is net earnings over shares outstanding. Change measured against the close of 18 Nov 2026.
Figure 11.2 Three year price scenarios

Sensitivity analysis

Table 11.3 Sensitivity of implied price to revenue CAGR and operating margin at 12x P/E
Revenue CAGR \ Operating margin8%10%12%14%16%
(3%)$7.51$10.96$14.41$17.87$21.32
(1%)$8.38$12.05$15.72$19.40$23.07
1%$9.29$13.19$17.09$20.99$24.88
3%$10.23$14.37$18.50$22.64$26.77
5%$11.21$15.60$19.98$24.36$28.74
Cells show implied share price in year 3. Close 18 Nov 2026 $13.66. Blue cells sit above it, red cells below. Other inputs as in the base case (report assumptions): net interest $80m, tax rate 25%, 2% fewer shares. FY2026 operating margin was 11.6%.
Table 11.4 Sensitivity of implied price to exit P/E and operating margin at 1% revenue CAGR
Exit P/E \ Operating margin8%10%12%14%16%
8x$6.19$8.79$11.39$13.99$16.59
10x$7.74$10.99$14.24$17.49$20.74
12x$9.29$13.19$17.09$20.99$24.88
14x$10.83$15.38$19.93$24.48$29.03
16x$12.38$17.58$22.78$27.98$33.18
Cells show implied share price in year 3. Close 18 Nov 2026 $13.66. Blue cells sit above it, red cells below. Other inputs as in the base case (report assumptions): net interest $80m, tax rate 25%, 2% fewer shares. FY2026 operating margin was 11.6%.

Disclaimer

This analysis is for information only and is not financial advice. It is derived from public SEC filings retrieved via sec-api.io and is not a publication of the U.S. Securities and Exchange Commission. Scenario values are model outputs under stated assumptions and are not forecasts. Data as of 19 November 2026.

Sources

All company and peer figures are read from SEC filings retrieved through the sec-api.io MCP server. Category data are those BellRing reports in its 8-K Ex 99.2. Share prices are regular session closes as dated in the text.

Table A.1 Filings used, with accession numbers
FormPeriodFiledAccession number
8-K Ex 99.1, 99.2, 99.330 Sep 202618 Nov 20260001628280-26-074645
10-K30 Sep 202618 Nov 20260001772016-26-000027
10-Q30 Jun 20264 Aug 20260001772016-26-000022
10-Q31 Mar 20265 May 20260001772016-26-000012
10-Q31 Dec 20253 Feb 20260001772016-26-000007
10-K30 Sep 202518 Nov 20250001772016-25-000153
10-K30 Sep 202419 Nov 20240001772016-24-000108
10-K30 Sep 202321 Nov 20230001772016-23-000091
10-Q30 Jun 20255 Aug 20250001772016-25-000127
10-Q31 Mar 20256 May 20250001772016-25-000081
10-Q31 Dec 20244 Feb 20250001772016-25-000028
8-K Ex 99.130 Sep 202518 Nov 20250001628280-25-052773
8-K Items 8.01, 9.0120 Nov 202520 Nov 20250001628280-25-053329
8-K Items 5.072 Feb 20262 Feb 20260001628280-26-004642
8-K Items 2.02, 5.02, 9.013 Feb 20263 Feb 20260001628280-26-004789
8-K Items 5.0223 Feb 202623 Feb 20260001628280-26-010629
8-K Items 2.02, 9.015 May 20265 May 20260001628280-26-030115
8-K Items 5.02, 8.0124 Jun 202624 Jun 20260001628280-26-045287
8-K Items 5.02, 7.01, 9.018 Jul 20268 Jul 20260001628280-26-047674
8-K Items 2.02, 9.014 Aug 20264 Aug 20260001628280-26-052137
Schedule 13G/A, BlackRock30 Sep 202627 Oct 20260002012383-26-003760
Schedule 13G, Goldman Sachs30 Sep 20269 Nov 20260000886982-26-000538
Schedule 13G, Vanguard Capital Management31 Mar 20263 Sep 20260002100119-26-001529
Schedule 13G, Vanguard Portfolio Management31 Mar 20263 Sep 20260002100121-26-001019
Schedule 13G/A, AQR30 Sep 202612 Nov 20260001167557-26-000230
Schedule 13G/A, Ameriprise30 Sep 202616 Nov 20260001193125-26-462560
Form 4, director purchase13 May 202614 May 20260001628280-26-035151
Form 4, director purchase8 Sep 20269 Sep 20260001628280-26-061167
Form 4, director purchase29 Jan 202611 Mar 20260001628280-26-016917
Form 4, plan sale1 Dec 20253 Dec 20250001628280-25-055090
Table A.2 Peer filings used
CompanyFormFiledAccession number
Abbott8-K Ex 99.121 Oct 20260001628280-26-066601
Celsius Holdings10-K2 Mar 20260001341766-26-000024
Celsius Holdings8-K Ex 99.15 Nov 20260001341766-26-000059
Celsius Holdings10-Q5 Nov 20260001341766-26-000062
Coca‑Cola8-K Item 8.0116 Jul 20260001628280-26-048466
Coca‑Cola8-K Ex 99.127 Oct 20260001628280-26-067403
Post Holdings10-K21 Nov 20250001530950-25-000260
Post Holdings8-K Ex 99.16 Aug 20260001530950-26-000076
Post Holdings10-Q6 Aug 20260001530950-26-000077
Simply Good Foods8-K Ex 99.127 Oct 20260001702744-26-000028
Simply Good Foods10-K27 Oct 20260001702744-26-000031
Table B.1 Exhibits to Forms 8-K filed in the last twelve months
FiledExhibitDocumentContent
20 Nov 2025Ex 99.1$600m repurchase authorization$600m authorization over two years from 19 Nov 2025; about $123m bought under the cancelled $400m authorization of 2 Sep 2025
3 Feb 2026Ex 99.1Q1 FY2026 resultsnet sales $537.3m, +0.8%; gross margin 29.9% against 37.5%; 3.0m shares bought for $96.9m at $31.95; $543.1m authorization left
3 Feb 2026Ex 99.2Q1 FY2026 supplemental presentationPremier RTD consumption (2.2%), Premier powder +2.9%, Dymatize +7.5% (13 weeks); consumption data are third party market data and management estimates of untracked channels as filed
3 Feb 2026Ex 99.3CEO leadership transitionCEO Darcy Davenport to retire on the earlier of a successor appointment or 30 Sep 2026; external search for a successor
5 May 2026Ex 99.1Q2 FY2026 resultsnet sales $598.7m, +1.8%: volume +10.8%, price/mix (9.0%); $11.3m charge for an ingredient that failed quality standards; FY2026 Adjusted EBITDA outlook $315m to $335m
5 May 2026Ex 99.2Q2 FY2026 supplemental presentationPremier RTD consumption +2.9%, powder +3.1%, Dymatize +6.0% (13 weeks)
8 Jul 2026Ex 99.1CEO appointmentMichael Axelrod, former CEO of Snak King and Del Real Foods, CEO from 29 Jul 2026; base salary $1.0m; equity award $4.75m, 40% RSUs and 60% PRSUs
4 Aug 2026Ex 99.1Q3 FY2026 resultsnet sales $570.4m, +4.2%; Dymatize +26.7% on price/mix +20.7%; $10.0m excess shake bottle inventory charge; FY2026 Adjusted EBITDA outlook $275m to $295m
4 Aug 2026Ex 99.2Q3 FY2026 supplemental presentationPremier RTD consumption +6.0%, powder (4.2%), Dymatize +2.7% (13 weeks)
18 Nov 2026Ex 99.1Q4 and FY2026 results, FY2027 outlookQ4 net sales $692.0m, +6.8%: volume +14.9%, price/mix (8.1%); Adjusted EBITDA $66.4m; FY2027 net sales $2.32bn to $2.42bn, Adjusted EBITDA $310m to $350m; long term targets withdrawn
18 Nov 2026Ex 99.2Q4 FY2026 supplemental presentationRTD category +12%, ready to mix +9% (13 weeks); 25% of RTD volume sold on price reduction; Premier RTD share 23.1%; distribution points +36%; household penetration 22.4%, repeat rate 54%
18 Nov 2026Ex 99.3CFO transitionTravis Leonard, former CFO of Lockton and Hostess Brands, CFO from 1 Dec 2026; Paul Rode advises to 28 Feb 2027